Form D · Biotechnology
PrimeGen Biotech LLC
Santa Ana, CA · CIK 0001617353
Offering snapshot reported Aug 4, 2016 · SEC filing
- Reported sold
- $400K Offering amount: $400K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2016 | Initial | $400,000 | No comparison | 1 | SEC filing |
| May 12, 2016 | Initial | $1,660,000 | No comparison | 1 | SEC filing |
| Jan 25, 2016 | Initial | $1,030,000 | No comparison | 1 | SEC filing |
| Jul 22, 2015 | Initial | $1,369,000 | No comparison | 1 | SEC filing |
| Jul 22, 2015 | Initial | $450,000 | No comparison | 1 | SEC filing |
| Aug 22, 2014 | Initial | $17,600,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-268370
Class B Preferred Units
Source: Form D, filed Aug 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven D. Gershick | Director |
| Lenard Makowka | Director |
| Wai Sun Szeto | Director |
| Thomas C.K. Yuen | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2917 S. Daimler Street
Santa Ana, CA, 92705
Santa Ana, CA, 92705